Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Inventor Minnie Malik
Introduction: Minnie Malik, an accomplished inventor based in Olney, OH, has made significant strides in the field of cancer research and treatment. With one patent to her name, her inventive efforts are focused on developing effective therapies that harness the properties of anthocyanins to combat cancer cell growth.
Latest Patents: Malik holds a patent for "Anthocyanin-rich compositions and methods for inhibiting cancer cell growth." This groundbreaking invention provides novel compositions and methods aimed at inhibiting the growth and cell cycle progression of carcinoma cells. Specifically, the method involves contacting carcinoma cells with an anthocyanin-rich extract (ARE) in an amount that effectively inhibits cancerous cells while leaving normal cells unaffected. The composition is particularly noted for its extracts derived from chokeberry, bilberry, grape, or combinations thereof, with a special emphasis on colon carcinoma cells.
Career Highlights: Minnie Malik is currently associated with the University System of Maryland, where she leverages her expertise in medicinal research to advance innovative treatment options. Her dedication to scientific exploration in the field of cancer therapy has proven pivotal in her research endeavors.
Collaborations: Throughout her career, Malik has collaborated with esteemed colleagues, including Bernadene Ann Magnuson and M Monica Giusti. Their joint efforts underscore the importance of teamwork in advancing research and developing effective therapeutic solutions that could potentially transform cancer treatment.
Conclusion: Minnie Malik's contributions to cancer research exemplify the spirit of innovation and dedication to improving health through science. Her patent for anthocyanin-rich compositions showcases her commitment to finding solutions that specifically target cancer cells without harming normal cells. As the medical field continues to evolve, her work will remain a valuable asset in the pursuit of effective cancer therapies.